Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors - PubMed (original) (raw)

Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors

Michael S Dirks et al. J Neurosurg. 2012 Jul.

Abstract

Object: Neurofibromatosis Type 2 (NF2) is a heritable tumor predisposition syndrome that leads to the development of multiple intracranial tumors, including meningiomas and schwannomas. Because the natural history of these tumors has not been determined, their optimal management has not been established. To define the natural history of NF2-associated intracranial tumors and to optimize management strategies, the authors evaluated long-term clinical and radiographic data in patients with NF2.

Methods: Consecutive NF2 patients with a minimum of 4 years of serial clinical and MRI follow-up were analyzed.

Results: Seventeen patients, 9 males and 8 females, were included in this analysis (mean follow-up 9.5±4.8 years, range 4.0-20.7 years). The mean age at initial evaluation was 33.2±15.5 years (range 12.3-57.6 years). Patients harbored 182 intracranial neoplasms, 164 of which were assessable for growth rate analysis (18 vestibular schwannomas [VSs], 11 nonvestibular cranial nerve [CN] schwannomas, and 135 meningiomas) and 152 of which were assessable for growth pattern analysis (15 VSs, 9 nonvestibular CN schwannomas, and 128 meningiomas). New tumors developed in patients over the course of the imaging follow-up: 66 meningiomas, 2 VSs, and 2 nonvestibular CN schwannomas. Overall, 45 tumors (29.6%) exhibited linear growth, 17 tumors (11.2%) exhibited exponential growth, and 90 tumors (59.2%) displayed a saltatory growth pattern characterized by alternating periods of growth and quiescence (mean quiescent period 2.3±2.1 years, range 0.4-11.7 years). Further, the saltatory pattern was the most frequently identified growth pattern for each tumor type: meningiomas 60.9%, VSs 46.7%, and nonvestibular schwannoma 55.6%. A younger age at the onset of NF2-related symptoms (p=0.01) and female sex (p=0.05) were associated with an increased growth rate in meningiomas. The identification of saltatory growth in meningiomas increased with the duration of follow-up (p=0.01).

Conclusions: Neurofibromatosis Type 2-associated intracranial tumors most frequently demonstrated a saltatory growth pattern. Because new tumors can develop in NF2 patients over their lifetime and because radiographic progression and symptom formation are unpredictable, resection may be best reserved for symptom-producing tumors. Moreover, establishing the efficacy of nonsurgical therapeutic interventions must be based on long-term follow-up (several years).

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Upper: Graph of planum meningioma growth revealing an extended period of quiescence (5.5 years). Growth rate from Time Point 1 to 2 averaged < 0.02 cm3/year. Lower: Axial contrast-enhanced registered MR images demonstrating the absence of tumor growth between Time Points 1 (left) and 2 (right).

Fig. 2

Fig. 2

Upper: Graph depicting tumor growth following SRS for the management of VS in a patient with NF2. Stereotactic radiosurgery was performed for the right VS immediately before the first available imaging studies. The left VS was untreated until resection (X). Vertical line at the 2-year mark indicates how much the left tumor grew (natural history) versus the right radiated tumor in the same interval. Lower: Axial contrast-enhanced registered MR images demonstrating growth of the right VS (left, asterisk) after SRS and the natural history of the contralateral VS (left and right). Note multiple histologically proven posterior fossa meningiomas (arrows) that were removed at the time of the VS surgeries.

Comment in

References

    1. Abaza MM, Makariou E, Armstrong M, Lalwani AK. Growth rate characteristics of acoustic neuromas associated with neu-rofibromatosis type 2. Laryngoscope. 1996;106:694–699. -PubMed
    1. Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg. 2006;105:248–255. -PubMed
    1. Asthagiri AR, Mehta GU, Zach L, Li X, Butman JA, Camphausen KA, et al. Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neurooncol. 2010;12:80–86. -PMC -PubMed
    1. Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, et al. Neurofibromatosis type 2. Lancet. 2009;373:1974–1986. -PMC -PubMed
    1. Baser ME, Friedman JM, Aeschliman D, Joe H, Wallace AJ, Ramsden RT, et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet. 2002;71:715–723. -PMC -PubMed

Publication types

MeSH terms

LinkOut - more resources